378 related articles for article (PubMed ID: 32615989)
1. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
4. Medium-chain fatty acids reduce serum cholesterol by regulating the metabolism of bile acid in C57BL/6J mice.
Liu Y; Zhang Y; Zhang X; Xu Q; Yang X; Xue C
Food Funct; 2017 Jan; 8(1):291-298. PubMed ID: 28009872
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models.
Cui Y; Li Z; Zhao E; Zhang J; Cui N
EXCLI J; 2012; 11():593-603. PubMed ID: 27847447
[No Abstract] [Full Text] [Related]
6. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
7. Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
Kim MH; Lee EJ; Kim SJ; Jung YJ; Park WJ; Park I
PLoS One; 2023; 18(6):e0287146. PubMed ID: 37310967
[TBL] [Abstract][Full Text] [Related]
8. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
10. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.
Jiang ZY; Parini P; Eggertsen G; Davis MA; Hu H; Suo GJ; Zhang SD; Rudel LL; Han TQ; Einarsson C
J Lipid Res; 2008 Feb; 49(2):464-72. PubMed ID: 18007013
[TBL] [Abstract][Full Text] [Related]
11. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
[TBL] [Abstract][Full Text] [Related]
12. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Yinchenhao Decoction on Cholesterol Gallstone in Mice Fed a Lithogenic Diet by Regulating LXR, CYP7A1, CYP7B1, and HMGCR Pathways.
Meng Y; Meng K; Zhao X; Li D; Gao Q; Wu S; Cui Y
Evid Based Complement Alternat Med; 2018; 2018():8134918. PubMed ID: 30310412
[TBL] [Abstract][Full Text] [Related]
14. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
[TBL] [Abstract][Full Text] [Related]
15. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
[TBL] [Abstract][Full Text] [Related]
16. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells.
Byun HW; Hong EM; Park SH; Koh DH; Choi MH; Jang HJ; Kae SH; Lee J
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):65-73. PubMed ID: 24463082
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
19. PPARγ overexpression regulates cholesterol metabolism in human L02 hepatocytes.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
J Pharmacol Sci; 2019 Jan; 139(1):1-8. PubMed ID: 30554802
[TBL] [Abstract][Full Text] [Related]
20. Piperine prevents cholesterol gallstones formation in mice.
Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]